Prestige Consumer Healthcare Inc.
NYSE:PBH
73.79 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,125.357 | 1,127.725 | 1,086.812 | 943.365 | 963.01 | 975.777 | 1,041.179 | 882.06 | 806.247 | 714.623 | 601.881 | 623.597 | 441.085 | 336.51 | 302.023 | 312.715 | 326.603 | 318.634 | 296.668 | 303.318 | 87.92 | 71.734 | 46.253 | 8.655 |
| Cost of Revenue
| 523.461 | 502.431 | 466.166 | 395.893 | 410.787 | 420.201 | 464.674 | 381.774 | 339.036 | 308.4 | 261.83 | 276.381 | 213.701 | 165.632 | 144.587 | 149.445 | 158.096 | 153.147 | 139.43 | 141.348 | 36.277 | 27.017 | 18.735 | 3.075 |
| Gross Profit
| 601.896 | 625.294 | 620.646 | 547.472 | 552.223 | 555.576 | 576.505 | 500.286 | 467.211 | 406.223 | 340.051 | 347.216 | 227.384 | 170.878 | 157.436 | 163.27 | 168.507 | 165.487 | 157.238 | 161.97 | 51.643 | 44.717 | 27.518 | 5.58 |
| Gross Profit Ratio
| 0.535 | 0.554 | 0.571 | 0.58 | 0.573 | 0.569 | 0.554 | 0.567 | 0.579 | 0.568 | 0.565 | 0.557 | 0.516 | 0.508 | 0.521 | 0.522 | 0.516 | 0.519 | 0.53 | 0.534 | 0.587 | 0.623 | 0.595 | 0.645 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 106.152 | 107.354 | 108.516 | 85.54 | 89.112 | 89.759 | 184.925 | 89.143 | 72.418 | 81.273 | 48.481 | 51.467 | 56.7 | 41.96 | 34.195 | 31.888 | 31.414 | 28.416 | 21.158 | 20.198 | -3.202 | 0 | 0 | 0.56 |
| Selling & Marketing Expenses
| 153.315 | 145.061 | 157.343 | 140.589 | 147.194 | 143.09 | 147.286 | 128.359 | 110.802 | 99.651 | 89.468 | 90.63 | 57.127 | 42.897 | 31.236 | 38.099 | 34.665 | 32.005 | 32.082 | 38.402 | 14.29 | 0 | 0 | 0.149 |
| SG&A
| 259.467 | 252.415 | 265.859 | 226.129 | 236.306 | 232.849 | 332.211 | 217.502 | 183.22 | 180.924 | 137.949 | 142.097 | 113.827 | 84.857 | 65.431 | 69.987 | 66.079 | 60.421 | 53.24 | 58.6 | 11.088 | 12.075 | 8.576 | 0.709 |
| Other Expenses
| 0.756 | 25.077 | 24.868 | 23.941 | 24.762 | -0.476 | 28.428 | 25.351 | 23.676 | 17.74 | 13.486 | 13.235 | 10.734 | 9.876 | 10.552 | 11.219 | 11.014 | 10.384 | 20.094 | 9.8 | 23.752 | 5.274 | 3.992 | 0 |
| Operating Expenses
| 259.467 | 277.492 | 290.727 | 250.07 | 261.068 | 259.896 | 360.639 | 242.853 | 206.896 | 198.664 | 151.435 | 155.332 | 124.561 | 94.733 | 75.983 | 81.206 | 77.093 | 70.805 | 73.334 | 68.4 | 34.84 | 17.349 | 12.568 | 0.709 |
| Operating Income
| 342.429 | 345.466 | 329.919 | 297.402 | 291.155 | 67.503 | 215.866 | 205.613 | 260.315 | 207.559 | 188.616 | 191.884 | 102.823 | 76.145 | 78.702 | -167.526 | 91.414 | 94.682 | 83.904 | 93.57 | 16.803 | 27.368 | 14.95 | 4.871 |
| Operating Income Ratio
| 0.304 | 0.306 | 0.304 | 0.315 | 0.302 | 0.069 | 0.207 | 0.233 | 0.323 | 0.29 | 0.313 | 0.308 | 0.233 | 0.226 | 0.261 | -0.536 | 0.28 | 0.297 | 0.283 | 0.308 | 0.191 | 0.382 | 0.323 | 0.563 |
| Total Other Income Expenses Net
| -66.404 | -439.381 | -67.461 | -93.289 | -100.004 | -228.653 | -2.901 | -53.24 | -17.97 | 1.133 | -18.286 | -1.443 | -0.346 | -0.3 | -5.407 | -249.59 | 0.187 | -39.506 | -9.317 | -26.863 | -9.882 | -21.548 | -13.971 | -2.48 |
| Income Before Tax
| 276.025 | -93.915 | 262.458 | 204.113 | 191.151 | -38.055 | 107.086 | 110.85 | 157.185 | 127.458 | 101.748 | 106.034 | 61.157 | 48.528 | 53.111 | -195.962 | 54.208 | 55.176 | 47.558 | 21.981 | 6.921 | 5.82 | 0.979 | 2.391 |
| Income Before Tax Ratio
| 0.245 | -0.083 | 0.241 | 0.216 | 0.198 | -0.039 | 0.103 | 0.126 | 0.195 | 0.178 | 0.169 | 0.17 | 0.139 | 0.144 | 0.176 | -0.627 | 0.166 | 0.173 | 0.16 | 0.072 | 0.079 | 0.081 | 0.021 | 0.276 |
| Income Tax Expense
| 66.686 | -11.609 | 57.077 | 39.431 | 48.87 | -2.255 | -232.484 | 41.455 | 57.278 | 49.198 | 29.133 | 40.529 | 23.945 | 19.349 | 21.849 | -9.186 | 20.289 | 19.098 | 21.281 | 8.522 | 2.738 | 20.716 | 0.434 | -0.137 |
| Net Income
| 209.339 | -82.306 | 205.381 | 164.682 | 142.281 | -35.8 | 339.57 | 69.395 | 99.907 | 78.26 | 72.615 | 65.505 | 37.212 | 29.22 | 32.115 | -186.776 | 33.919 | 36.078 | 26.277 | 13.459 | 4.183 | -14.896 | 0.545 | 2.528 |
| Net Income Ratio
| 0.186 | -0.073 | 0.189 | 0.175 | 0.148 | -0.037 | 0.326 | 0.079 | 0.124 | 0.11 | 0.121 | 0.105 | 0.084 | 0.087 | 0.106 | -0.597 | 0.104 | 0.113 | 0.089 | 0.044 | 0.048 | -0.208 | 0.012 | 0.292 |
| EPS
| 4.21 | -1.65 | 4.09 | 3.28 | 2.81 | -0.69 | 6.34 | 1.31 | 1.89 | 1.5 | 1.41 | 1.29 | 0.74 | 0.58 | 0.64 | -3.74 | 0.68 | 0.73 | 0.54 | -0.55 | 0.02 | -0.3 | -0.55 | 0.1 |
| EPS Diluted
| 4.17 | -1.65 | 4.04 | 3.25 | 2.78 | -0.69 | 6.34 | 1.3 | 1.88 | 1.49 | 1.39 | 1.27 | 0.73 | 0.58 | 0.64 | -3.74 | 0.68 | 0.72 | 0.53 | -0.55 | 0.02 | -0.3 | -0.55 | 0.095 |
| EBITDA
| 373.104 | 378.091 | 360.959 | 328.932 | 318.867 | 327.2 | 249.68 | 283.428 | 284.153 | 225.391 | 202.162 | 205.132 | 113.575 | 86.253 | 94.83 | 93.426 | 105.248 | 108.323 | 106.647 | 133.176 | 22.232 | 32.642 | 18.942 | 4.871 |
| EBITDA Ratio
| 0.332 | 0.335 | 0.332 | 0.349 | 0.331 | 0.335 | 0.24 | 0.321 | 0.352 | 0.315 | 0.336 | 0.329 | 0.257 | 0.256 | 0.314 | 0.299 | 0.322 | 0.34 | 0.359 | 0.439 | 0.253 | 0.455 | 0.41 | 0.563 |